(0.27%) 5 475.09 points
(0.13%) 39 170 points
(0.83%) 17 879 points
(0.05%) $83.42
(0.16%) $2.48
(0.12%) $2 341.80
(1.52%) $29.75
(0.38%) $992.50
(0.05%) $0.931
(0.16%) $10.66
(0.03%) $0.791
(0.00%) $86.75
@ $54.94
Issued: 1 Jul 2024 @ 14:26
Return: -0.43%
Previous signal: Jun 28 - 15:42
Previous signal:
Return: 2.59 %
Live Chart Being Loaded With Signals
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases...
Stats | |
---|---|
Today's Volume | 1.92M |
Average Volume | 1.99M |
Market Cap | 6.27B |
EPS | $-1.330 ( Q1 | 2024-05-10 ) |
Next earnings date | ( $-1.020 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-10.13 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $2.62 (4.79%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-07-01 | Parshall B Lynne | Buy | 5 000 | Common Stock |
2024-07-01 | Parshall B Lynne | Sell | 5 000 | Common Stock |
2024-07-01 | Parshall B Lynne | Sell | 5 000 | Non-Qualified Stock Option (Right to Buy) |
2024-07-01 | Blum Robert I | Sell | 11 500 | Common Stock |
2024-06-25 | Malik Fady Ibraham | Buy | 5 300 | Common Stock |
INSIDER POWER |
---|
4.76 |
Last 95 transactions |
Buy: 565 689 | Sell: 523 580 |
Volume Correlation
Cytokinetics Inc Correlation
10 Most Positive Correlations | |
---|---|
OZEM | 1 |
KLXE | 0.905 |
AGRI | 0.903 |
BNAI | 0.901 |
BRLT | 0.9 |
FWRD | 0.897 |
SVC | 0.893 |
PZZA | 0.892 |
BCTX | 0.89 |
CHUY | 0.888 |
10 Most Negative Correlations | |
---|---|
RFAIU | -0.918 |
GOGL | -0.9 |
GODN | -0.893 |
IBKR | -0.892 |
AFAR | -0.89 |
ACGL | -0.886 |
WING | -0.884 |
BYNO | -0.882 |
SFM | -0.877 |
APXI | -0.877 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cytokinetics Inc Correlation - Currency/Commodity
Cytokinetics Inc Financials
Annual | 2023 |
Revenue: | $7.53M |
Gross Profit: | $-4.36M (-57.93 %) |
EPS: | $-5.45 |
FY | 2023 |
Revenue: | $7.53M |
Gross Profit: | $-4.36M (-57.93 %) |
EPS: | $-5.45 |
FY | 2022 |
Revenue: | $94.59M |
Gross Profit: | $-146.23M (-154.59 %) |
EPS: | $-4.48 |
FY | 2021 |
Revenue: | $70.43M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.68 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cytokinetics Inc
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators